Compare Recursion Pharmaceuticals Inc (RXRX) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Recursion Pharmaceuticals Inc vs Tilray Brands Inc — how do they compare? Recursion Pharmaceuticals Inc trades at $3.07 (market cap $1.53B), while Tilray Brands Inc trades at $4.24 (market cap $524.07M). The key difference: Recursion Pharmaceuticals Inc is far larger — about 2.9× Tilray Brands Inc's market cap. Which is the better fit depends on your goals.
| RXRX | TLRY | |
|---|---|---|
Market Cap | $1.53B | $524.07M |
Sector | Health | Health |
52-Week High | $6.79 | $21.00 |
52-Week Low | $2.84 | $4.23 |
Enterprise Value | $946.50M | $621.22M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
